{'fraction_non_alphanumeric': 0.01842374616171955, 'fraction_numerical': 0.006141248720573183, 'mean_word_length': 5.150943396226415, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Various diagnostic and therapeutic aspects of myasthenia in children and adolescents].

Data of examining 32 patients with myasthenia treated at the Institute of Children's Neurology and Psychiatry in Belgrade are presented. Among these patients there were no children with the neonatal transitory form of myasthenia. In two children being treated, the disease symptoms appeared since the birth or soon after it and had been then persisting for a long time (the neonatal persistent form of myasthenia). In 30 children, the disease began before or soon after the age of 10 year. The juvenile form of myasthenia gravis could be divided into the early and the late ones, with regard to the patients' age and the disease clinical course. Modern diagnostic tests and their significance in diagnosing myasthenia gravis and myasthenic syndromes in children and adolescents are considered, and present-day aspects of treating myasthenia gravis in the patients mentioned are discussed.